THE SLCO1B1 GENE POLYMORPHISM AND STATIN-INDUCED MYOPATHY IN RUSSIAN PATIENTS
Aim. To evaluate the risk of muscle tissue damage in patients taking statins, and usefulness of the gene SLCO1B1 typifying for the risk estimation of such an unpleasant adverse drug reaction (ADR).Material and methods. The observation of 258 patients with ischemic heart disease, taking statins, was...
Saved in:
Main Authors: | V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina, O. V. Shatalova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2014-10-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/51 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01) -
INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: V. I. Petrov, et al.
Published: (2015-09-01) -
Evaluation of the effect of the carrier of polymorphic variants of the SLCO1B1 gene on efficacy and safety in patients during treatment with statins
by: N. A. Rumyantsev, et al.
Published: (2018-02-01) -
The value of pharmacogenetic markers for personalized approach to the statins treatment
by: N. V. Kokh, et al.
Published: (2013-09-01) -
Statin-Induced Myopathy
by: D. A. Sychev, et al.
Published: (2023-09-01)